Device Trial Radar · NCT03273907
Post Approval Study of the CyPass System
Last checked: Nov 20, 2026Latest source record: Feb 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
79
Actual
Start
Oct 12, 2017
Primary completion
Aug 31, 2021
Study completion Aug 31, 2021
Sponsor
- Lead sponsor
- Alcon ResearchNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 6, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate that the rate of clinically relevant complications associated with CyPass Micro-Stent placement and stability using the CyPass 241-S applier, as determined at 36 months in the postmarket setting, is less than the pre-specified performance target, which is based on experience with the CyPass Model E applier in COMPASS trial TMI-09-01 (NCT01085357).
Conditions
- Primary Open-angle Glaucoma
- Cataract
Interventions
CyPass Micro-Stent implanted with CyPass 241-S applierDevice
CyPass System (Model 241-S) consists of the CyPass Micro-Stent contained in a loading device (loader) and the CyPass applier.The CyPass Micro-Stent is an implantable medical device intended for long term use.
Cataract surgeryProcedure
Cataract surgery, followed by implantation of the CyPass Micro-Stent in one eye (the study eye) at the surgery visit
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Eyes With Clinically Relevant Complications Associated With CyPass Micro-Stent Placement and Stability as Determined at Month 36Time frame: Up to Month 36 postoperative
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Alcon Investigative Site
Phoenix, Arizona
Alcon Investigative Site
Orange, California
Alcon Investigative Site
Fort Collins, Colorado
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.